Platelet-derived growth factor A and B chains and the α and β receptors in prostatic intraepithelial neoplasia

Prostate

Volumn 29, Issue 5, 1996, Pages 282-286

  Fudge, Kim ^a   Bostwick, David G ^b   Stearns, Mark E ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

adenocarcinoma; platelet derived growth factor; prostatic intraepithelial neoplasia

Indexed keywords

PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ARTICLE; CARCINOMA IN SITU; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

CARCINOMA IN SITU; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOENZYME TECHNIQUES; MALE; PLATELET-DERIVED GROWTH FACTOR; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR;

EID: 0029804549     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199611)29:5<282::AID-PROS2>3.0.CO;2-C     Document Type: Article

References (16)

1. Bostwick DG, Brawer MK: Prostatic intraepithelial neoplasia and early invasion in prostate cancer. Cancer 59: 788, 1987.
2. Boone CW, Kelloff GJ, Steele V: Histopathology of the pre-malignant process. Cancer Bull 43:481, 1991.
3. Bostwick DG: Prostatic intraepithelial neoplasia (PIN): Current concepts. J Cell Biochem 16H(suppl):10, 1992.
4. Helpap B: The biologic significance of atypical hyperplasia of the prostate. Virchows Arch [A] 387:307, 1980.
5. Kastendieck H, Helpap B: Prostatic "dysplasia/atypical hyperplasia." Urology 34(suppl):28, 1989.
6. McNeal JE, Bostwick DG: Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 17:64, 1986.
7. Kovi J, Mostofi FK, Heshmat MY, Enterline JP: Large acinar atypical hyperplasia and carcinoma of the prostate. Cancer 61:555, 1988.
8. De La Torre M, Haggman M, Brandstedt S, Busch C: Prostatic intraepithelial neoplasia and invasive carcinoma in total prostatectomy specimens: Distribution, volumes and DNA ploidy. Br J Urol 72:207, 1993.
9. Brawer MK: Prostatic intraepithelial neoplasia: A premalignant lesion. J Cell Biochem 16G(suppl):171, 1992.
10. Nagle RB, Petein M, Brawer M, Bowden GT, Cress AE: New relationships between prostatic intraepithelial neoplasia and prostatic carcinoma. J Cell Biochem 16H(suppl):26, 1992.
11. McNeal JE, Leav I, Alroy J, Skutelsky E: Differential lectin staining of central and peripheral zones of the prostate and alterations in dysplasia. Am J Clin Pathol 89:41, 1988.
12. McNeal JE, Alroy J, Leav I, Redwine EA, Freiha FS, Stamey TA: Immunohistochemical evidence of impaired cell differentiation in the premalignant phase of prostate carcinogenesis. Am J Clin Pathol 90:23, 1988.
13. Perlman EJ, Epstein JI: Blood group antigen expression in dysplasia and adenocarcinoma of the prostate. Lab Invest 60:72A, 1989.
14. Maygarden SJ: Applications of immunohistochemistry to the diagnosis and prognostication of prostate carcinoma and prostatic intraepithelial neoplasia. Pathol Annu 29:303, 1994.
15. Fudge K, Wang CY, Stearns ME: Immunohistochemistry analysis of platelet derived growth factor A and B chains and platelet derived growth factor alpha and beta receptor expression in benign prostatic hyperplasias and Gleason graded human prostatic adenocarcinomas. Mod Pathol 7:549, 1994.
16. Troncoso P, Babaian RJ, Ro JY, Grignon DJ, von Eschenbach BC, Ayala AG: Prostatic intraepithelial neoplasia and invasive prostatic adenocarcinoma in cytoprostatectomy specimens. Urology 34:52, 1989.